It is also tempting to speculate that FUNDC2 may play a physiological role in the metabolism of normal liver tissue via inhibition of MFN1, and altered mitochondrial dynamics due to attenuated FUNDC2 expression may contribute to the pathogenesis of NAFLD. Here, MFN1 is linked to metabolic dysfunction-associated steatotic liver disease.